Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Shareholders who have questions or need assistance in voting should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 (North American Toll Free) or 1-416-304-0211 (Outside North ...

House of Artisans, an initiative under The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) which is dedicated ...

New U.S. Senator Jim Justice has earned a reputation for dodging fines, ignoring court orders, breaking contracts, and paying ...

Tiger Global-backed Innovacer, healthcare-focused software-as-a-service startup (SaaS), has secured $275 million in a ...

Under the patronage of His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE, Abu Dhabi Sustainability Week ...

Elena Rybakina has confirmed her first post-Australian Open tournament as the world No. 6 will return to Abu Dhabi between ...

The deal counter is buzzing with new funding rounds across sectors. This and more in today’s ETtech Morning Dispatch.

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

U.S. law firm Skadden, Arps, Slate, Meagher & Flom on Thursday said it has opened an office in Abu Dhabi, following other ...

Defiant is a new early-stage VC firm focused on B2B SaaS and fintech coming out of stealth Thursday. Joseph Pizzolato ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...